tiprankstipranks
Trending News
More News >
Advertisement

FICS - ETF AI Analysis

Compare

Top Page

FICS

First Trust International Developed Capital Strength ETF (FICS)

Rating:70Neutral
Price Target:
$42.00
The First Trust International Developed Capital Strength ETF (FICS) has a solid overall rating, reflecting a balanced portfolio of strong-performing international stocks. Holdings like GlaxoSmithKline contribute positively with robust growth in specialty medicines, successful R&D efforts, and an attractive dividend yield. However, stocks such as Pan Pacific International Holdings slightly weigh down the rating due to bearish momentum and relatively high valuation. Investors should note the ETF's exposure to diverse sectors and regions, which helps mitigate risks but may also limit concentrated growth opportunities.
Positive Factors
Strong Top Holdings
Several key holdings, such as Toronto Dominion Bank and Imperial Oil, have delivered strong year-to-date performance, supporting the fund’s returns.
Broad Geographic Exposure
The ETF invests across multiple countries, including the UK, Switzerland, and Japan, reducing reliance on any single market.
Defensive Sector Allocation
Significant exposure to financial and consumer defensive sectors provides stability during market volatility.
Negative Factors
High Expense Ratio
The ETF charges a relatively high expense ratio compared to many other funds, which can eat into investor returns over time.
Mixed Recent Performance
Short-term performance has been inconsistent, with negative returns over the past three months despite gains year-to-date.
Underperforming Holding
Compass, one of the top holdings, has lagged with negative year-to-date performance, potentially dragging on overall returns.

FICS vs. SPDR S&P 500 ETF (SPY)

FICS Summary

The First Trust International Developed Capital Strength ETF (FICS) is an investment fund that focuses on financially strong companies in developed markets outside the U.S. It follows the International Developed Capital Strength Index and includes well-known companies like Nestlé and L'Oréal. This ETF is diversified across sectors like financials, consumer goods, and healthcare, and spans countries such as the UK, Switzerland, and Japan. Investors might consider FICS for global diversification and exposure to stable, high-quality companies. However, new investors should note that its performance can be affected by changes in international markets and currency fluctuations.
How much will it cost me?The First Trust International Developed Capital Strength ETF (FICS) has an expense ratio of 0.7%, which means you’ll pay $7 per year for every $1,000 invested. This is higher than average because the fund is actively managed, focusing on selecting companies with strong financial health and growth potential across developed markets outside the U.S.
What would affect this ETF?The First Trust International Developed Capital Strength ETF (FICS) could benefit from stable economic growth in developed markets outside the U.S., particularly if sectors like Financials and Consumer Defensive continue to perform well. However, challenges such as rising interest rates or economic slowdowns in key regions could negatively impact its holdings, especially in sectors like Industrials and Consumer Cyclical. Regulatory changes or geopolitical tensions in developed markets may also influence the ETF's performance.

FICS Top 10 Holdings

The First Trust International Developed Capital Strength ETF leans heavily on financials, with Toronto Dominion Bank standing out as a steady performer, buoyed by strong earnings and strategic growth initiatives. Consumer defensive names like Nestlé and Reckitt are rising, thanks to robust financial health and consistent market demand, while Coca Cola HBC is lagging, weighed down by mixed technical indicators. Meanwhile, industrials like Compass are struggling to gain traction, adding a touch of turbulence. With its focus on developed markets outside the U.S., the fund offers a global mix but remains concentrated in financial and consumer sectors.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Imperial Oil2.25%$4.82M$46.38B29.52%
74
Outperform
Itochu2.21%$4.74M¥13.68T25.50%
70
Outperform
Singtel2.17%$4.65MS$76.42B49.27%
70
Outperform
Next plc2.16%$4.63M£16.61B47.25%
75
Outperform
GlaxoSmithKline2.16%$4.62M£71.07B26.84%
77
Outperform
Prudential2.15%$4.61M£27.19B67.91%
70
Outperform
Pan Pacific International Holdings2.09%$4.48M¥3.14T25.44%
66
Neutral
Poste Italiane SPA2.09%$4.47M€26.98B57.10%
69
Neutral
Great-West Lifeco2.08%$4.45MC$55.13B23.04%
76
Outperform
AstraZeneca2.08%$4.45M£199.98B31.46%
76
Outperform

FICS Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
38.51
Positive
100DMA
38.64
Positive
200DMA
37.84
Positive
Market Momentum
MACD
0.02
Negative
RSI
59.58
Neutral
STOCH
57.65
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FICS, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 38.73, equal to the 50-day MA of 38.51, and equal to the 200-day MA of 37.84, indicating a bullish trend. The MACD of 0.02 indicates Negative momentum. The RSI at 59.58 is Neutral, neither overbought nor oversold. The STOCH value of 57.65 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FICS.

FICS Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$212.65M0.70%
70
Neutral
$991.68M0.50%
65
Neutral
$856.61M0.24%
63
Neutral
$757.79M0.50%
64
Neutral
$642.90M0.34%
58
Neutral
$565.39M0.39%
63
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
FICS
First Trust International Developed Capital Strength ETF
39.12
4.90
14.32%
TOUS
T. Rowe Price International Equity ETF
DFSI
Dimensional International Sustainability Core 1 ETF
SEIE
SEI Select International Equity ETF
IMFL
Invesco International Developed Dynamic Multifactor ETF
TLTD
FlexShares Morningstar Developed Markets ex-US Factor Tilt
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement